Pub. Date : 2017 Oct 19
PMID : 29045207
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | CONCLUSIONS: In this trial involving patients with active psoriatic arthritis who had had an inadequate response to TNF inhibitors, tofacitinib was more effective than placebo over 3 months in reducing disease activity. | tofacitinib | tumor necrosis factor | Homo sapiens |
| 2 | Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors. | tofacitinib | tumor necrosis factor | Homo sapiens |
| 3 | We evaluated tofacitinib in patients with active psoriatic arthritis who had previously had an inadequate response to tumor necrosis factor (TNF) inhibitors. | tofacitinib | tumor necrosis factor | Homo sapiens |
| 4 | We evaluated tofacitinib in patients with active psoriatic arthritis who had previously had an inadequate response to tumor necrosis factor (TNF) inhibitors. | tofacitinib | tumor necrosis factor | Homo sapiens |